+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 20Years - 65Years
All Genders
ID07022704

Effect of Intravenous Doxapram on Diaphragm Movement in Adults with COPD on Mechanical Ventilation During Breathing Trials

Led by Cairo University · Updated on 2025-06-26

35

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of doxapram on diaphragmatic movement in patients with moderate to severe chronic obstructive pulmonary disease COPD who are undergoing a spontaneous breathing trial while mechanically ventilated. The purpose is to evaluate how doxapram influences breathing muscle function during this trial. This is a prospective observational study sponsored by Cairo University. During the spontaneous breathing trial, all participants will receive doxapram intravenously at a dose of 1.5 mgkg ten minutes after the trial starts. The movement of the diaphragm will be assessed using respiratory muscle ultrasound by an expert. This treatment and evaluation occur during the breathing trial period. Participants will be monitored before and ten minutes after receiving doxapram for diaphragmatic movement measured in millimeters. Additionally, arterial blood gases and respiratory rate will be recorded at these same times. The study involves observing these outcomes to understand the impact of doxapram on respiratory function during the breathing trial. The study is planned to continue until November 2025.

CONDITIONS

Brief Title

Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

Research Team

M

Mina Helmy, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here